(E) -Aztreonam

(E) -Aztreonam (SQ-28429) is a monocyclic beta-lactam antibiotic. (E) -Aztreonam has the potential for the research of infections caused by gram-negative pathogens[1][2][3].

Product Specifications

CAS Number

[99341-02-3]

Product Name Alternative

SQ-28429

UNSPSC

12352005

Hazard Statement

H302, H312, H332

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/e-aztreonam.html

Purity

98.68

Solubility

DMSO : 100 mg/mL

Smiles

CC(C)(O/N=C(C1=CSC(N)=N1)/C(N[C@H]2[C@H](C)N(S(=O)(O)=O)C2=O)=O)C(O)=O

Molecular Formula

C13H17N5O8S2

Molecular Weight

435.43

Precautions

H302, H312, H332

References & Citations

[1]Neu HC. Aztreonam activity, pharmacology, and clinical uses. Am J Med. 1990 Mar 23;88 (3C) :2S-6S; discussion 38S-42S.|[2]Childs, S. J., et al. Aztreonam. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986, 6 (4), 138-149.|[3]Ortega E, et al. Effects of aztreonam on natural immunity in mice. Int J Antimicrob Agents. 1999 Sep;13 (1) :41-6.